Ligand modulation of a dinuclear platinum compound leads to mechanistic differences in cell cycle progression and arrest.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochemical Pharmacology

• Publication date

  2013-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2013.10.012PMID 24161784PMCID PMC3932533
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.

  2013cited by this paper
• Clinical Pharmacokinetics and Administration of Established Platinum Drugs

  2012cited by this paper
• DNA interstrand crosslinks induce a potent replication block followed by formation and repair of double strand breaks in intact mammalian cells.

  2012cited by this paper
• Progress in platinum derived drug development

  2012cited by this paper
• CDDO-Imidazolide Induces DNA Damage, G2/M Arrest and Apoptosis in BRCA1-Mutated Breast Cancer Cells

  2011cited by this paper
• DNA interstrand crosslink repair and cancer

  2011cited by this paper
• Solution studies of dinuclear polyamine-linked platinum-based antitumour complexes.

  2011cited by this paper
• Novel bis-platinum complexes endowed with an improved pharmacological profile.

  2010cited by this paper
• Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles.

  2010cited by this paper
• Excursions in polynuclear platinum DNA binding.

  2010cited by this paper
• The polynuclear platinum BBR3610 induces G2/M arrest and autophagy early and apoptosis late in glioma cells.

  2010cited by this paper
• Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin

  2009cited by this paper
• New combination therapies with cell-cycle agents.

  2008cited by this paper
• Mechanisms and functions of DNA mismatch repair

  2008cited by this paper
• Cell cycle arrest by oxaliplatin on cancer cells

  2007cited by this paper
• The role of sulfur in platinum anticancer chemotherapy.

  2007cited by this paper
• Mismatch Repair Status and the Response of Human Cells to Cisplatin

  2007cited by this paper
• Possible biotransformation reactions of polynuclear Pt(II) complexes.

  2007cited by this paper
• Low-Dose BBR3610 Toxicity in Colon Cancer Cells Is p53-Independent and Enhanced by Inhibition of Epidermal Growth Factor Receptor (ERBB1)-Phosphatidyl Inositol 3 Kinase Signaling

  2007cited by this paper
• Dinuclear platinum complexes with biological relevance based on the 1,2-diaminocyclohexane carrier ligand.

  2007cited by this paper
• Recruitment of DNA Damage Checkpoint Proteins to Damage in Transcribed and Nontranscribed Sequences

  2006cited by this paper
• Cell cycle arrest and apoptosis induced by oxaliplatin (L-OHP) on four human cancer cell lines.

  2006cited by this paper
• The multifaceted mismatch-repair system

  2006cited by this paper
• Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells

  2005cited by this paper
• Caspase-dependent apoptosis and -independent poly(ADP-ribose) polymerase cleavage induced by transforming growth factor beta1.

  2004cited by this paper
• ATR functions as a gene dosage‐dependent tumor suppressor on a mismatch repair‐deficient background

  2004cited by this paper
• Living with or without cyclins and cyclin-dependent kinases.

  2004cited by this paper
• Sensitive species-specific monitoring of a new triplatinum anti-cancer drug and its potential related compounds in spiked human plasma by cation-exchange HPLC-ICP-MS

  2003cited by this paper
• Reaction of polynuclear platinum antitumor compounds with reduced glutathione studied by multinuclear (1H, 1H-15N gradient heteronuclear single-quantum coherence, and 195Pt) NMR spectroscopy.

  2003cited by this paper
• A comparison of DNA binding profiles of dinuclear platinum compounds with polyamine linkers and the trinuclear platinum phase II clinical agent BBR3464

  2002cited by this paper
• DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464

  2002cited by this paper
• ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1

  2001cited by this paper
• Cell cycle checkpoint signaling through the ATM and ATR kinases.

  2001cited by this paper
• Conformation, Recognition by High Mobility Group Domain Proteins, and Nucleotide Excision Repair of DNA Intrastrand Cross-links of Novel Antitumor Trinuclear Platinum Complex BBR3464*

  2001cited by this paper
• The tumour suppressor protein p53 can repress transcription of cyclin B.

  2000cited by this paper
• Proteases for Cell Suicide: Functions and Regulation of Caspases

  2000influential reference
• BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.

  2000cited by this paper
• Anticancer drug targets: cell cycle and checkpoint control.

  1999cited by this paper
• p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells

  1998cited by this paper
• p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells.

  1998cited by this paper
• Recognition and repair of compound DNA lesions (base damage and mismatch) by human mismatch repair and excision repair systems

  1997cited by this paper
• ATF/CREB site mediated transcriptional activation and p53 dependent repression of the cyclin A promoter

  1996cited by this paper
• Loss of DNA mismatch repair in acquired resistance to cisplatin.

  1996cited by this paper
• DNA damage checkpoints: implications for cancer therapy.

  1996cited by this paper
• Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.

  1992cited by this paper
• Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay.

  1990cited by this paper

• Elevated NDRG1 Expression Drives Oxaliplatin Chemoresistance in Bladder Cancer Cells by Promoting Homologous Recombination Repair and Inhibiting G2/M Arrest.

  2025cites this paper
• Antitumor active trans‑platinum complexes through metabolic stability and enhanced cellular accumulation.

  2023cites this paper
• Oxaliplatin and its derivatives – An overview

  2023cites this paper
• Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages

  2023cites this paper
• Equilibrium Studies on Pd(II)–Amine Complexes with Bio-Relevant Ligands in Reference to Their Antitumor Activity

  2023cites this paper
• Exploring heterometallic bridged Pt(II)-Zn(II) complexes as potential antitumor agents.

  2022cites this paper
• LSD1‐Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1‐Induced p62 Transcription in HCC

  2021cites this paper
• Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease

  2021cites this paper
• NUF2 as an anticancer therapeutic target and prognostic factor in breast cancer.

  2020cites this paper
• Nitric oxide-donor/PARP-inhibitor combination: A new approach for sensitization to ionizing radiation

  2019cites this paper
• Novel fluorinated platinum(II) complexes with pyridine-2-carboxylate ligand as potent radiosensitizer and antiviral agent

  2018cites this paper
• Cytotoxic platinum coordination compounds. DNA binding agents

  2017cites this paper
• Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells.

  2017cites this paper
• Platinum-zoledronate complex blocks gastric cancer cell proliferation by inducing cell cycle arrest and apoptosis

  2016cites this paper
• New trends in platinum and palladium complexes as antineoplastic agents

  2016cites this paper
• Development of Non-Traditional Platinum Anticancer Agents: trans-Platinum Planar Amine Compounds and Polynuclear Platinum Compounds

  2015cites this paper
• Synthesis and characterization of trans-Pt(II)(salicylaldimine)(pyridine/pyridine-4-carbinol)Cl complexes: In vivo inhibition of E. coli growth and in vitro anticancer activities

  2015cites this paper
• Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.

  2015cites this paper
• Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.

  2015cites this paper
• siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo

  2014cites this paper
• A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089

  2014cites this paper
• Nucleolar Targeting by Platinum: p53-Independent Apoptosis Follows rRNA Inhibition, Cell-Cycle Arrest, and DNA Compaction

  2014cites this paper
• Synthesis, characterization and cytotoxic activity of novel platinum(II) iodido complexes.

  2014cites this paper
• Tracking the processing of damaged DNA double-strand break ends by ligation-mediated PCR: increased persistence of 3′-phosphoglycolate termini in SCAN1 cells

  2013cites this paper